Basic Information
RNALocate ID: RLID:01001781
RNA Symbol: hsa-miR-140-5p
Localization: Nucleus
RNA Information
RNA Name: hsa-miR-140
RNA ID: miRBase:MIMAT0000431
RNA Category: miRNA
Species: Homo sapiens
Sequence:
Localization Information
PubMed ID: 24918059
Tissue/Cell Line: Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa)
Method: Microarray
Description: Data are collected from supplementary Table S2. MiRNA reads in the subcellular fractions.
Other Subcellular Localization
RNALocate ID Localization Tissue/Cell line PubMed ID
RLID:01001779 Cytoplasm Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) 24918059
RLID:01001780 Mitochondrion Skeletal muscle myoblasts 21637849
RLID:01001782 Nucleus Neural progenitor cells 21363885
RLID:11001761 Exosome Primary ovarian tumor cells|Serum 18589210
RLID:11001762 Exosome Primary dendritic cells|T cell line (J77) 21505438
RLID:11001763 Exosome Renal cancer cells 21670082
RLID:11001764 Exosome Breast milk 22211110
RLID:11001765 Exosome Brain tissue 23382797
RLID:11001766 Exosome Plasma 23663360
RLID:11001767 Exosome Cerebrospinal fluid 25420022
RLID-D:11000359 Microvesicle Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine
RLID-D:11001177 Exosome Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine
ncRNA Disease Information
Resource RNA Symbol Disease Link
MNDR hsa-miR-140-5p Multiple sclerosis chronic progressive MNDR-E-MI-13465
MNDR hsa-miR-140-5p Oral squamous cell carcinoma MNDR-E-MI-13466
MNDR hsa-miR-140-5p Large cell neuroendocrine cancer MNDR-E-MI-13467
MNDR hsa-miR-140-5p Medulloblastoma MNDR-E-MI-13468
MNDR hsa-miR-140-5p High-grade serous ovarian carcinoma MNDR-E-MI-13469
MNDR hsa-miR-140-5p Uterine corpus endometrial carcinoma MNDR-E-MI-13470
MNDR hsa-miR-140-5p Lymphoma MNDR-E-MI-13471
MNDR hsa-miR-140-5p Estrogen-receptor positive breast cancer MNDR-E-MI-13472
MNDR hsa-miR-140-5p Estrogen-receptor negative breast cancer MNDR-E-MI-13473
MNDR hsa-miR-140-5p Progesterone-receptor positive breast cancer MNDR-E-MI-13474
MNDR hsa-miR-140-5p Progesterone-receptor negative breast cancer MNDR-E-MI-13475
MNDR hsa-miR-140-5p Her2-receptor positive breast cancer MNDR-E-MI-13476
MNDR hsa-miR-140-5p Niemann-pick disease type c MNDR-E-MI-13477
MNDR hsa-miR-140-5p Precursor cell lymphoblastic leukemia-lymphoma MNDR-E-MI-13478
MNDR hsa-miR-140-5p B cell acute lymphoblastic leukemia MNDR-E-MI-13479
MNDR hsa-miR-140-5p Prostate cancer MNDR-E-MI-13480
MNDR hsa-miR-140-5p Gastric cancer MNDR-E-MI-13481
MNDR hsa-miR-140-5p Alzheimer disease MNDR-E-MI-13482
MNDR hsa-miR-140-5p Sickle cell anemia MNDR-E-MI-13483
MNDR hsa-miR-140-5p Intracranial aneurysm MNDR-E-MI-13484
MNDR hsa-miR-140-5p Urinary bladder cancer MNDR-E-MI-13485
MNDR hsa-miR-140-5p Dysautonomia familial MNDR-E-MI-13486
MNDR hsa-miR-140-5p Head and neck cancer MNDR-E-MI-13487
MNDR hsa-miR-140-5p Leukemia MNDR-E-MI-13488
MNDR hsa-miR-140-5p Cardiovascular disease MNDR-E-MI-13489
MNDR hsa-miR-140-5p Lung cancer MNDR-E-MI-13490
MNDR hsa-miR-140-5p Fragile x syndrome MNDR-E-MI-13491
MNDR hsa-miR-140-5p Parkinson disease MNDR-E-MI-13492
MNDR hsa-miR-140-5p Niemann-pick disease MNDR-E-MI-13493
MNDR hsa-miR-140-5p Primary pulmonary hypertension MNDR-E-MI-13494
MNDR hsa-miR-140-5p Breast cancer MNDR-E-MI-13495
MNDR hsa-miR-140-5p Squamous cell carcinoma MNDR-E-MI-13496
MNDR hsa-miR-140-5p Pituitary neoplasms MNDR-E-MI-13497
MNDR hsa-miR-140-5p Pancreatic cancer MNDR-E-MI-13498
MNDR hsa-miR-140-5p Melanoma MNDR-E-MI-13499
MNDR hsa-miR-140-5p Rectum adenocarcinoma MNDR-E-MI-13500
MNDR hsa-miR-140-5p Nephroblastoma MNDR-E-MI-13501
MNDR hsa-miR-140-5p Colon cancer MNDR-E-MI-13502
MNDR hsa-miR-140-5p Ischemic attack transient MNDR-E-MI-13503
MNDR hsa-miR-140-5p Colon adenocarcinoma MNDR-E-MI-13504
MNDR hsa-miR-140-5p Multiple sclerosis MNDR-E-MI-13505
MNDR hsa-miR-140-5p Multiple sclerosis relapsing-remitting MNDR-E-MI-13506
MNDR hsa-miR-140-5p Familial ovarian cancer MNDR-E-MI-13507
MNDR hsa-miR-140-5p Prostate adenocarcinoma MNDR-E-MI-13508
MNDR hsa-miR-140-5p Carcinoma ductal breast MNDR-E-MI-13509
MNDR hsa-miR-140-5p Glioblastoma MNDR-E-MI-13510
MNDR hsa-miR-140-5p Glioma MNDR-E-MI-13511
MNDR hsa-miR-140-5p Amyotrophic lateral sclerosis MNDR-E-MI-13512
MNDR hsa-miR-140-5p Osteosarcoma MNDR-E-MI-13513
MNDR hsa-miR-140-5p Liposarcoma MNDR-E-MI-13514
MNDR hsa-miR-140-5p Meningioma MNDR-E-MI-13515
MNDR hsa-miR-140-5p Liver cancer MNDR-E-MI-13516
MNDR hsa-miR-140-5p Uterine cancer MNDR-E-MI-13517
MNDR hsa-miR-140-5p Gastric adenocarcinoma MNDR-E-MI-13518
MNDR hsa-miR-140-5p Cervical squamous cell carcinoma MNDR-E-MI-13519
MNDR hsa-miR-140-5p Pituitary adenoma MNDR-E-MI-13520
MNDR hsa-miR-140-5p Lung squamous cell carcinoma MNDR-E-MI-13521
MNDR hsa-miR-140-5p Non-small cell lung adenocarcinoma MNDR-E-MI-13522
MNDR hsa-miR-140-5p Lung adenocarcinoma MNDR-E-MI-13523
MNDR hsa-miR-140-5p Adrenocortical cancer MNDR-E-MI-13524
MNDR hsa-miR-140-5p Thyroid carcinoma MNDR-E-MI-13525
MNDR hsa-miR-140-5p Ovarian carcinoma MNDR-E-MI-13526
MNDR hsa-miR-140-5p Bladder urothelial carcinoma MNDR-E-MI-13527
MNDR hsa-miR-140-5p Pancreatic adenocarcinoma MNDR-E-MI-13528
MNDR hsa-miR-140-5p Brain stem cancer MNDR-E-MI-13529
MNDR hsa-miR-140-5p Myasthenia gravis autoimmune experimental MNDR-E-MI-13530
MNDR hsa-miR-140-5p Kidney renal clear cell carcinoma MNDR-E-MI-13531
MNDR hsa-miR-140-5p Kidney renal papillary cell carcinoma MNDR-E-MI-13532
MNDR hsa-miR-140-5p Clear cell renal cell carcinoma MNDR-E-MI-13533
MNDR hsa-miR-140-5p Large cell carcinoma MNDR-E-MI-13534
MNDR hsa-miR-140-5p Cholangiocarcinoma MNDR-E-MI-13535
MNDR hsa-miR-140-5p Esophageal cancer MNDR-E-MI-13536
MNDR hsa-miR-140-5p Lung small cell carcinoma MNDR-E-MI-13537
MNDR hsa-miR-140-5p Head and neck squamous cell carcinoma MNDR-E-MI-13538
MNDR hsa-miR-140-5p Testicular germ cell cancer MNDR-E-MI-13539
MNDR hsa-miR-140-5p T acute lymphoblastic leukemia MNDR-E-MI-13540
MNDR hsa-miR-140-5p Acute t cell leukemia MNDR-E-MI-13541
MNDR hsa-miR-140-5p Adenoma MNDR-E-MI-13542
MNDR hsa-miR-140-5p Breast invasive carcinoma MNDR-E-MI-13543
MNDR hsa-miR-140-5p Hepatocellular carcinoma MNDR-E-MI-13544
MNDR hsa-miR-140-5p Familiar ovarian carcinoma MNDR-E-MI-13545
MNDR hsa-miR-140-5p B-cell lymphoma MNDR-E-MI-13546
MNDR hsa-miR-140-5p Retinoblastoma MNDR-E-MI-13547
MNDR hsa-miR-140-5p Osteoarthritis MNDR-E-MI-13548
MNDR hsa-miR-140-5p Hypopharynx cancer MNDR-E-MI-13549
MNDR hsa-miR-140-5p Hodgkin lymphoma MNDR-E-MI-13550
MNDR hsa-miR-140-5p Tonsil cancer MNDR-E-MI-13551
MNDR hsa-miR-140-5p Skin cutaneous melanoma MNDR-E-MI-13552
MNDR hsa-miR-140-5p Skin melanoma MNDR-E-MI-13553
MNDR hsa-miR-140-5p Acute myelocytic leukemia MNDR-E-MI-13554
MNDR hsa-miR-140-5p Colorectal cancer MNDR-E-MI-13555
MNDR hsa-miR-140-5p Nasopharynx carcinoma MNDR-E-MI-13556
MNDR hsa-miR-140-5p Multiple myeloma MNDR-E-MI-13557
MNDR hsa-miR-140-5p Acute lymphocytic leukemia MNDR-E-MI-13558
MNDR hsa-miR-140-5p Ovarian epithelial cancer MNDR-E-MI-13559
MNDR hsa-miR-140-5p Cardiomegaly MNDR-E-MI-13560
MNDR hsa-miR-140-5p Nasopharyngeal cancer MNDR-E-MI-13561
MNDR hsa-miR-140-5p Stroke lacunar MNDR-E-MI-13562
MNDR hsa-miR-140-5p Non-alcoholic fatty liver disease MNDR-E-MI-13563
MNDR hsa-miR-140-5p Breast cancer her3+ negative MNDR-E-MI-13564
MNDR hsa-miR-140-5p Hypopharyngeal carcinoma MNDR-E-MI-13565
MNDR hsa-miR-140-5p Hypopharyngeal squamous cell carcinoma MNDR-E-MI-13566
MNDR hsa-miR-140-5p Solid-pseudopapillary neoplasm of pancreas MNDR-E-MI-13567
MNDR hsa-miR-140-5p Tubulovillous adenoma MNDR-E-MI-13568
RNA Interaction Information
Resource RNA Symbol Species Link RNALocate ID
RNAInter ADA Homo sapiens RR00039907
TOP